Quality Payment Program: Collect MIPS Points for COVID-19 Clinical Trial Submissions

Why This Topic Matters

It matters because the article describes a new CMS reporting option that may affect how clinicians document qualifying research participation under MIPS, while also highlighting audit-related resources that support compliance preparation.

Article Sections

1. Background and MIPS scoring impact

   Introduces the CMS update within the Quality Payment Program and explains how it fits into broader MIPS scoring and performance categories.

2. New COVID-19 Clinical Trials Improvement Activity

   Summarizes the new improvement activity option and the general circumstances around clinician participation in COVID-19 research reporting.

3. How this option affects overall scoring

   Describes the category-weight context for MIPS and why the new activity may be relevant to annual performance totals.

4. IT input and open source tools

   Discusses CMS encouragement to use data tools and the broader technology and submission context for clinical trial reporting.

5. Get Ready for MIPS Audits

   Covers the separate update on MIPS data validation materials and the agency’s audit-related documentation resources.

6. Details, note, and resources

   Points to CMS resource locations and external reference materials related to the update.